Literature DB >> 31285379

Intramedullary cervical spinal mass after stem cell transplantation using an olfactory mucosal cell autograft.

Claire F Woodworth1, Gregory Jenkins1, Jane Barron1, Nanette Hache2.   

Abstract

Mesh：

Year:  2019        PMID： 31285379      PMCID： PMC6739061          DOI： 10.1503/cmaj.181696

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

Review 1.  Cell transplantation therapy for spinal cord injury.

Authors:  Peggy Assinck; Greg J Duncan; Brett J Hilton; Jason R Plemel; Wolfram Tetzlaff
Journal:  Nat Neurosci       Date:  2017-04-25       Impact factor: 24.884

2.  Global Distribution of Businesses Marketing Stem Cell-Based Interventions.

Authors:  Israel Berger; Amina Ahmad; Akhil Bansal; Tanvir Kapoor; Douglas Sipp; John E J Rasko
Journal:  Cell Stem Cell       Date:  2016-08-04       Impact factor: 24.633

3.  Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study.

Authors:  Carlos Lima; José Pratas-Vital; Pedro Escada; Armando Hasse-Ferreira; Clara Capucho; Jean D Peduzzi
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

4.  Motor evoked potential and voluntary EMG activity after olfactory mucosal autograft transplantation in a case of chronic, complete spinal cord injury: case report.

Authors:  Koichi Iwatsuki; Fumihiro Tajima; Yoshiyuki Sankai; Yu-Ichiro Ohnishi; Takeshi Nakamura; Masahiro Ishihara; Koichi Hosomi; Koshi Ninomiya; Takashi Moriwaki; Toshiki Yoshimine
Journal:  Spinal Cord Ser Cases       Date:  2016-01-07

5.  Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord.

Authors:  Jike Lu; François Féron; Alan Mackay-Sim; Phil M E Waite
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

6.  Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.

Authors:  Michelle Bowman; Michael Racke; John Kissel; Jaime Imitola
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

7.  Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report.

Authors:  Brian J Dlouhy; Olatilewa Awe; Rajesh C Rao; Patricia A Kirby; Patrick W Hitchon
Journal:  J Neurosurg Spine       Date:  2014-07-08

8.  Autologous olfactory [corrected] mucosal transplant in chronic spinal cord injury: an Indian Pilot Study.

Authors:  H S Chhabra; C Lima; S Sachdeva; A Mittal; V Nigam; D Chaturvedi; M Arora; A Aggarwal; R Kapur; T A H Khan
Journal:  Spinal Cord       Date:  2009-06-02       Impact factor: 2.772

9.  Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury.

Authors:  Carlos Lima; Pedro Escada; José Pratas-Vital; Catarina Branco; Carlo Alberto Arcangeli; Giovanna Lazzeri; Carlos Alberto Santana Maia; Clara Capucho; Armando Hasse-Ferreira; Jean D Peduzzi
Journal:  Neurorehabil Neural Repair       Date:  2009-09-30       Impact factor: 3.919

10.  Human spinal autografts of olfactory epithelial stem cells recapitulate donor site histology, maintaining proliferative and differentiation capacity many years after transplantation.

Authors:  Kevin S Chen; Jeremy C McIntyre; Andrew P Lieberman; Jeffrey R Martens; Parag G Patil
Journal:  Acta Neuropathol       Date:  2016-02-02       Impact factor: 17.088
View more
  10 in total

1.  Experimental Treatments for Spinal Cord Injury: What you Should Know.

Authors:  Vieri Failli; Naomi Kleitman; Daniel P Lammertse; Jane T C Hsieh; John D Steeves; James W Fawcett; Mark H Tuszynski; Armin Curt; Michael G Fehlings; James D Guest; Andrew R Blight
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

2.  Improved cell-purification techniques and safety monitoring needed for olfactory ensheathing cell transplantation.

Authors:  Richard D Bartlett; James B Phillips; David Choi
Journal:  CMAJ       Date:  2019-10-28       Impact factor: 8.262

Review 3.  Applying stem cell therapy in intractable diseases: a narrative review of decades of progress and challenges.

Authors:  Anna Pick Kiong Brianna; Ying Pei Ling
Journal:  Stem Cell Investig       Date:  2022-09-30

Review 4.  Therapeutic Potential of Niche-Specific Mesenchymal Stromal Cells for Spinal Cord Injury Repair.

Authors:  Susan L Lindsay; Susan C Barnett
Journal:  Cells       Date:  2021-04-14       Impact factor: 6.600

5.  Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials.

Authors:  Zhizhong Shang; Mingchuan Wang; Baolin Zhang; Xin Wang; Pingping Wanyan
Journal:  BMC Med       Date:  2022-09-05       Impact factor: 11.150

6.  The Direct to Consumer Stem Cell Market and the Role of Primary Care Providers in Correcting Misinformation.

Authors:  Jennifer R Arthurs; Charlene M Martin Lillie; Zubin Master; Shane A Shapiro
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec

7.  A scoping review of trials for cell-based therapies in human spinal cord injury.

Authors:  Alice G Willison; Sam Smith; Benjamin M Davies; Mark R N Kotter; Susan C Barnett
Journal:  Spinal Cord       Date:  2020-04-06       Impact factor: 2.772

8.  Regulated, reliable, and reputable: Protect patients with uniform standards for stem cell treatments.

Authors:  Geoffrey P Lomax; Art Torres; Maria T Millan
Journal:  Stem Cells Transl Med       Date:  2020-02-10       Impact factor: 6.940

9.  Sensitive manipulation of CAR T cell activity using a chimeric endocytosing receptor.

Authors:  Boning Zhang; John Victor Napoleon; Xin Liu; Qian Luo; Madduri Srinivasarao; Philip S Low
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

Review 10.  Understanding the Future Prospects of Synergizing Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery with Ceramics and Regenerative Cellular Therapies.

Authors:  Wen-Cheng Lo; Lung-Wen Tsai; Yi-Shan Yang; Ryan Wing Yuk Chan
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.